LDS? lol. The URL seems to indicate Dec 4th for the article. The latest date in the article being November 26th this seems reasonable.
Abu Jimoh, public relations manager of NAFDAC, who confirmed the development, told the magazine, Monday, November 26, that Xechem would be allowed to resume production after it has satisfied NAFDAC’s requirements. He said NAFDAC’s major concern was that Xechem must immediately employ a competent production pharmacist to oversee its quality control department.
drift, PCN is Pharmacists Council of Nigeria, not 'Potency'
imo the article is valid, and I believe the issues with the PCN and Nafdac have already been adressed, or are about to be, since it is already 10 days ago.
what I do not like are Nicosan is an expensive anti-sickle cell anaemia drug and
it is hardly found on the shelf of most registered pharmacies in the country.
yup, we have a long way to go. Perhaps the pps today is reflecting it's acurate value today, but surely not for six months from now. imo.
Market Data 
Markets 
AI
